|
2023 Conference Publication Liquid biopsy assessment in primary cutaneous diffuse large B-Cell lymphoma- leg typePham-Ledard, Anne, Guicheney, Marie, Ducharme, Oceane, Caumont, Charline, Gerard, Emilie, Dousset, Lea, Beylot-Barry, Marie, Merlio, Jean-Philippe and Gros, Audrey (2023). Liquid biopsy assessment in primary cutaneous diffuse large B-Cell lymphoma- leg type. 30th European Organisation for Research and Treatment of Cancer/ National Cancer Institute / American Association for Cancer Research Symposium (EORTC-NCI-AACR), Dublin Ireland, Nov 13-18, 2018. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/j.ejca.2023.113012 |
|
2019 Conference Publication Commonly Used Drugs in Rheumatology May Alter Anti-Tumoral Response to Immune Checkpoint InhibitorsKostine, Marie, Mauric, Eleonora, Barnetche, Thomas, Rouxel, Lea, Dutriaux, Caroline, Dousset, Lea, Prey, Sorilla, Beylot-Barry, Marie, Seneschal, Julien, Veillon, Remi, Charlotte, Vergnenegre, Daste, Amaury, Charlotte, Domblides, Sionneau, Baptiste, Gross-Goupi, Marine, Ravaud, Alain, Forcade, Edouard, Bannwarth, Bernard, Mehsen-Cetre, Nadia, Truchetet, Marie-Elise, Richez, Christophe and Schaeverbeke, Thierry (2019). Commonly Used Drugs in Rheumatology May Alter Anti-Tumoral Response to Immune Checkpoint Inhibitors. Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP), Atlanta Ga, Nov 08-13, 2019. HOBOKEN: WILEY. |
|
2019 Conference Publication COMMONLY USED DRUGS IN RHEUMATOLOGY MAY ALTER ANTI-TUMORAL RESPONSE TO IMMUNE CHECKPOINT INHIBITORSKostine, Marie, Mauric, Eleonora, Barnetche, Thomas, Rouxel, Lea, Dutriaux, Caroline, Dousset, Lea, Prey, Sorilla, Beylot-Barry, Marie, Seneschal, Julien, Veillon, Remi, Vergnenegre, Charlotte, Daste, Amaury, Domblides, Charlotte, Sionneau, Baptiste, Gross-Goupil, Marine, Ravaud, Alain, Forcade, Edouard, Bannwarth, Bernard, Truchetet, Marie-Elise, Richez, Christophe, Mehsen-Cetre, Nadia and Schaeverbeke, Thierry (2019). COMMONLY USED DRUGS IN RHEUMATOLOGY MAY ALTER ANTI-TUMORAL RESPONSE TO IMMUNE CHECKPOINT INHIBITORS. Annual European Congress of Rheumatology (EULAR), Madrid Spain, Jun 12-15, 2019. LONDON: BMJ PUBLISHING GROUP. doi: 10.1136/annrheumdis-2019-eular.7470 |
